VIP and rheumatoid arthritis: synthesized a vasoactive intestinal peptide‐loaded nanocomposite, UCNPs@SiO2@Pt@CeO2, for treating rheumatoid arthritis (RA).[227] New directions of RA treatment involve relieving hypoxia and removing synovial cells.